ESMO Breast 2021 | Ethnic differences in hereditary breast cancer

Yeon Hee Park, MD, PhD, Samsung Medical Center & Sungkyunkwan University School of Medicine, Seoul, Korea, discusses the ethnic heterogeneity of hereditary breast cancer, in particular commenting on differences in the ethnic prevalence of BRCA1 mutations and the use of PARP inhibitors. This interview took place at the virtual European Society for Medical Oncology (ESMO) Breast Cancer Congress 2021.